20.48
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
16.68%
49.00
|
42.00 | 36.52 | 32.94 | 31.45 |
| Operating Income/Loss |
16.68%
-49.00
|
-42.00 | -36.52 | -32.94 | -31.45 |
| Nonoperating Income/Loss |
27.92%
3.445
|
2.693 | 2.682 | 3.076 | 3.354 |
| Net Income/Loss |
15.91%
-45.56
|
-39.30 | -33.83 | -29.87 | -28.10 |
| Basic Average Shares |
6.88%
65.99
|
61.75 | 0.0784 | 59.67 | 59.55 |
| Diluted Average Shares |
6.88%
65.99
|
61.75 | 0.0784 | 59.67 | 59.55 |
| Basic Earnings Per Share |
7.81%
-0.69
|
-0.64 | -0.56 | -0.50 | -0.47 |
| Diluted Earnings Per Share |
7.81%
-0.69
|
-0.64 | -0.56 | -0.50 | -0.47 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):